Learn More
Abcam Gefitinib, EGFR tyrosine kinase inhibitor, 250MG
Supplier: Abcam AB142052250MG
MW 446.9 Da, Purity >98%. Orally active, potent, selective EGFR (Epidermal growth factor receptor) tyrosine kinase inhibitor (IC₅₀ = 33 nM). Inhibits EGF-stimulated EGFR autophosphorylation and inhibits tumor growth in vivo. Enhances efficacy of cytotoxic agents. Inhibits growth factor production and angiogenesis. Clinically useful anticancer agent.
The product is subject to the following: Abcam Restricted Use Statement
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.